Targeting CD36-Mediated Lipid Metabolism by Selective Inhibitor-Augmented Antitumor Immune Responses in Oral Cancer

Keyphrases

• Antitumor Immune Response 100%
• Oral Cancer 100%
• Lipid Metabolism 100%
• Selective Inhibitor 100%
• Oral Squamous Cell Carcinoma Cells 100%
• Cluster of Differentiation 36 (CD36) 100%
• Oleate 100%
• Sodium 83%
• Immune Cells 33%
• Tumor Progression 33%
• Surface Expression 33%
• Selective Inhibition 33%
• Antitumor Effect 33%
• Accessory Molecules 33%
• Mixed Lymphocyte Reaction 33%
• Expression Level 16%
• Regulatory T Cells 16%
• Tumor Growth 16%
• Programmed Death-ligand 1 (PD-L1) 16%
• In Cancer 16%
• Tumor Cells 16%
• Mouse Tumor 16%
• Immunomodulatory Effect 16%
• Apoptotic Cell Death 16%
• MHC Class II 16%
• Dendritic Cells 16%
• Malignant Cells 16%
• Immune Response 16%
• Cell Proliferation 16%
• Sodium Treatment 16%
• T Cell Proliferation 16%
• Inhibit Tumor 16%
• Cancer Immunotherapy 16%
• CD4+ T 16%
• Proliferation Apoptosis 16%
• T Cell Response 16%
• Suppressor T Cells 16%
• CD8+ T 16%
• Fatty Acid Receptor 16%
• Immune Suppressive Cells 16%
• CD83 16%

Immunology and Microbiology

• Immune Response 100%
• Lipid Metabolism 100%
• Carcinoma Cell 100%
• CD36 100%
• Immunity 50%
• Immunocompetent Cell 33%
• T Cell 33%
• Regulatory T Cell 33%
• Cell Surface 33%
• Mixed Lymphocyte Reaction 33%
• Programmed Cell Death 33%
• Programmed Death-Ligand 1 16%
• CD4 16%
• Myeloid 16%
• Dendritic Cell 16%
• Tumor Cell 16%
• CD8 16%
• Cell Proliferation 16%
• T Cell Proliferation 16%
• Cancer Immunotherapy 16%
• MHC Class II 16%
• CD83 16%